(Alliance News) - Vectura Group PLC on Tuesday said it has hired Will Downie as chief executive officer of the company with effect from November 7.
The pharmaceutical company said Downie spent ten years as senior vice president at Catalent Inc, where he "led the commercial effort and had responsibility for global sales, marketing and commercial operations activities." Prior to Catalent, Downie was a vice president and general manager at GE Healthcare, part of General Electric Co, and vice president sales at Amersham Health.
Downie will succeed interim chief executive Paul Fry, who was appointed to the role in June following the departure of James Ward-Lilley. Fry will resume his role as chief financial officer, Vectura said.
Chair Bruno Angelici said: "I am very pleased to welcome Will Downie as Vectura's new CEO. He brings a wealth of relevant experience which will help Vectura to grow and deliver on its new strategic focus as a leading inhaled CDMO business."
Vectura shares were up 0.8% in London at 83.90 on Tuesday.
By Loreta Juodagalvyte; loretajuodagalvyte@alliancenews.com
Copyright 2019 Alliance News Limited. All Rights Reserved.
